ℹ️
🇬🇧
Search
Search for people relevant for "Autoimmune Diseases"
Autoimmune Diseases
Person
Class
Person
Publication
Programmes
prof. MUDr. Tomáš Kozák Ph.D.
Academic staff at Third Faculty of Medicine
3 classes
138 publications
Classes
class
Hematology and Oncology
+1
C3VL008 |
Third Faculty of Medicine
class
ERASMUS - Hematology and Oncology
CERA3P0047 |
Third Faculty of Medicine
Publications
publication
Hematopoietic stem cell transplatation for multiple scerosis: A retrospective multicenter study
2002 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases
2002 |
Third Faculty of Medicine
publication
Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis
2001 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts - Our experiences with CellPro, E rosetting and CliniMACS technique
2001 |
Third Faculty of Medicine, Central Library of Charles University
publication
Collection of hematopoietic stem cells from patients with autoimmune diseases
2001 |
Third Faculty of Medicine
publication
Hematopoietic stem cell transplantation in autoimmune diseases in rheumatology practice
2000 |
Central Library of Charles University
publication
Immunoablation and hematopoietic stem cell transplantation in the treatment of multiple sclerosis
2000 |
Central Library of Charles University
publication
Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions
2024 |
Third Faculty of Medicine, Central Library of Charles University
publication
Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis
2023 |
First Faculty of Medicine, Third Faculty of Medicine
Load more publications (128)
Loading network view...